Published in Proc Natl Acad Sci U S A on January 02, 2001
Dietary iron controls circadian hepatic glucose metabolism through heme synthesis. Diabetes (2014) 1.46
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda. Proc Natl Acad Sci U S A (2007) 1.35
Structural basis for tetrapyrrole coordination by uroporphyrinogen decarboxylase. EMBO J (2003) 1.31
Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. PLoS One (2012) 1.08
A mouse chromosome 4 balancer ENU-mutagenesis screen isolates eleven lethal lines. BMC Genet (2009) 1.00
Targeted deletion of the mouse Mitoferrin1 gene: from anemia to protoporphyria. Blood (2011) 0.96
Down-regulation of hepcidin in porphyria cutanea tarda. Blood (2008) 0.86
Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions. Am J Hum Genet (2006) 0.85
Substrate shuttling between active sites of uroporphyrinogen decarboxylase is not required to generate coproporphyrinogen. J Mol Biol (2009) 0.83
Iron in skin of mice with three etiologies of systemic iron overload. J Invest Dermatol (2005) 0.83
Heme and erythropoieis: more than a structural role. Haematologica (2014) 0.82
Uroporphyria in the Cyp1a2-/- mouse. Blood Cells Mol Dis (2011) 0.79
Mass-spectrometric profiling of porphyrins in complex biological samples with fundamental, toxicological, and pharmacological applications. Anal Biochem (2015) 0.75
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell (1987) 20.47
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature (1988) 20.36
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A (1993) 20.33
HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A (1998) 3.35
Macrocyclic intermediates in the biosynthesis of porphyrins. Philos Trans R Soc Lond B Biol Sci (1976) 2.73
The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood (1999) 2.27
High-fidelity gene targeting in embryonic stem cells by using sequence replacement vectors. Mol Cell Biol (1992) 2.14
Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA. J Biol Chem (1986) 2.05
Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med (2000) 1.84
Cutaneous porphyria in Turkey. N Engl J Med (1960) 1.79
Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential decarboxylations of uroporphyrinogens I and III. J Biol Chem (1983) 1.50
Uroporphyrinogen decarboxylase structural mutant (Gly281----Glu) in a case of porphyria. Science (1986) 1.47
Isolation and identification of a cDNA clone coding for rat uroporphyrinogen decarboxylase. Proc Natl Acad Sci U S A (1984) 1.27
Crystal structure of human uroporphyrinogen decarboxylase. EMBO J (1998) 1.26
Porphyria cutanea tarda. Semin Liver Dis (1998) 1.18
Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood (2000) 1.14
Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet (1985) 1.11
Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology (1998) 1.06
Uroporphyrinogen decarboxylase in Saccharomyces cerevisiae. HEM12 gene sequence and evidence for two conserved glycines essential for enzymatic activity. Eur J Biochem (1992) 1.03
Characterization and crystallization of human uroporphyrinogen decarboxylase. Protein Sci (1997) 1.02
A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda. Blood (1989) 0.99
Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda. J Clin Invest (1990) 0.99
Order of uroporphyrinogen III decarboxylation on incubation of porphobilinogen and uroporphyrinogen III with erythrocyte uroporphyrinogen decarboxylase. Biochem J (1993) 0.98
Identification of a new mutation responsible for hepatoerythropoietic porphyria. Eur J Clin Invest (1991) 0.95
Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda. Toxicol Appl Pharmacol (1997) 0.95
Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria. J Invest Dermatol (1994) 0.93
Characterization of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria. Hum Genet (1992) 0.88
Genetic variation of iron-induced uroporphyria in mice. Biochem J (1993) 0.87
Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda. Gastroenterology (1993) 0.87
Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am J Hum Genet (1996) 0.85
Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles. Am J Hum Genet (1998) 0.85
Mouse uroporphyrinogen decarboxylase: cDNA cloning, expression, and mapping. Mamm Genome (1996) 0.78
Three new mutations in the uroporphyrinogen decarboxylase gene in familial porphyria cutanea tarda. Mutation in brief no. 237. Online. Hum Mutat (1999) 0.77
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature (1988) 20.36
p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell (1998) 11.54
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature (2000) 7.46
Positive and negative elements regulate human interleukin 3 expression. Proc Natl Acad Sci U S A (1990) 7.44
Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1981) 7.43
High frequency targeting of genes to specific sites in the mammalian genome. Cell (1986) 6.91
Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet (1997) 5.34
Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A (1998) 4.07
Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med (1988) 3.66
Targeting genes for self-excision in the germ line. Genes Dev (1999) 3.59
Introduction of homologous DNA sequences into mammalian cells induces mutations in the cognate gene. Nature (1986) 3.30
Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet (1999) 3.00
An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity. J Clin Invest (1976) 2.83
Temporary closure of open abdominal wounds by the modified sandwich-vacuum pack technique. Br J Surg (2003) 2.62
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest (2001) 2.49
A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest (1995) 2.48
Regulation of HeLa cell transferrin receptors. J Biol Chem (1982) 2.46
The Maf transcription factors: regulators of differentiation. Trends Biochem Sci (1997) 2.38
Screening for hemochromatosis. N Engl J Med (1993) 2.32
Preparation and properties of a national reference endotoxin. J Clin Microbiol (1976) 2.30
The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood (1999) 2.27
Maintenance of functional equivalence during paralogous Hox gene evolution. Nature (2000) 2.24
Protein kinase C regulates the nuclear localization of diacylglycerol kinase-zeta. Nature (1998) 2.20
Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med (1996) 2.15
Sexual loss in relation to other functional losses for spinal cord injured males. Arch Phys Med Rehabil (1976) 2.12
Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest (1992) 2.08
Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner. Mol Cell Biol (1993) 2.05
Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc Natl Acad Sci U S A (1987) 2.02
Genes that modify the hemochromatosis phenotype in mice. J Clin Invest (2000) 1.99
Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med (2000) 1.84
Poliovirus replicase stimulation by terminal uridylyl transferase. J Biol Chem (1985) 1.81
High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia (2006) 1.81
Purification of a terminal uridylyltransferase that acts as host factor in the in vitro poliovirus replicase reaction. Proc Natl Acad Sci U S A (1986) 1.80
Internalization and subcellular localization of transferrin and transferrin receptors in HeLa cells. J Biol Chem (1983) 1.80
Processivity of DNA exonucleases. J Biol Chem (1978) 1.73
Blood lead concentrations in hereditary hemochromatosis. J Lab Clin Med (1994) 1.71
Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett (2001) 1.68
The transcriptional integrator CREB-binding protein mediates positive cross talk between nuclear hormone receptors and the hematopoietic bZip protein p45/NF-E2. Mol Cell Biol (1997) 1.66
Location of crossovers during gene targeting with insertion and replacement vectors. Mol Cell Biol (1993) 1.64
In vivo footprinting of the human alpha-globin locus upstream regulatory element by guanine and adenine ligation-mediated polymerase chain reaction. Mol Cell Biol (1992) 1.61
Respiratory disease associated with practolol therapy. Lancet (1977) 1.61
Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol (1982) 1.61
Teratogenicity of patulin and patulin adducts formed with cysteine. Appl Environ Microbiol (1976) 1.60
Iron absorption in hypotransferrinemic mice. Blood (1991) 1.58
The G185R mutation disrupts function of the iron transporter Nramp2. Blood (1998) 1.56
The molecular defect in hypotransferrinemic mice. Blood (2000) 1.54
The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase. J Clin Invest (1975) 1.45
Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology (1989) 1.45
Expression of the DMT1 (NRAMP2/DCT1) iron transporter in mice with genetic iron overload disorders. Blood (2001) 1.43
Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem (2000) 1.41
Heme regulation of HeLa cell transferrin receptor number. J Biol Chem (1984) 1.40
Molecular cloning of a novel human diacylglycerol kinase highly selective for arachidonate-containing substrates. J Biol Chem (1996) 1.39
Hereditary haemochromatosis. Clin Haematol (1982) 1.38
Introduction of a lacZ reporter gene into the mouse int-2 locus by homologous recombination. Proc Natl Acad Sci U S A (1990) 1.36
Surgery for pulmonary aspergillosis. J Thorac Cardiovasc Surg (1969) 1.34
Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet (1997) 1.31
Homogeneous multiplex genotyping of hemochromatosis mutations with fluorescent hybridization probes. Am J Pathol (1998) 1.30
Idiopathic refractory sideroblastic anemia: clinical and laboratory investigation of 17 patients and review of the literature. Medicine (Baltimore) (1971) 1.26
Crystal structure of human uroporphyrinogen decarboxylase. EMBO J (1998) 1.26
Rapid enzyme system for the identification of pathogenic Neisseria spp. J Clin Microbiol (1985) 1.24
Mouse microcytic anaemia caused by a defect in the gene encoding the globin enhancer-binding protein NF-E2. Nature (1993) 1.23
Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase. Biochemistry (1983) 1.20
Porphyria cutanea tarda in three generations of a single family. N Engl J Med (1978) 1.19
Factors influencing the inhibitory effect of carbon monoxide on cytochrome P-450-catalyzed mixed function oxidation reactions. Ann N Y Acad Sci (1970) 1.17
Alcohol dependence and conduct disorder among Navajo Indians. J Stud Alcohol (1999) 1.17
Biochemical and genetic factors influencing drug metabolism. Influence of hepatic microsomal mixed function oxidation reactions on cellular metabolic control. Metabolism (1971) 1.17
Lattice-dictated conformers in bis(pyrazolyl)pyridine-based iron(II) complexes: Mössbauer, NMR, and magnetic studies. Inorg Chem (2001) 1.17
Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood (2000) 1.14
Allelic association under map error and recombinational heterogeneity: a tale of two sites. Proc Natl Acad Sci U S A (1998) 1.13
The Nramp2/DMT1 iron transporter is induced in the duodenum of microcytic anemia mk mice but is not properly targeted to the intestinal brush border. Blood (2000) 1.12
Alcohol dependence and domestic violence as sequelae of abuse and conduct disorder in childhood. Child Abuse Negl (1998) 1.11
A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic hematological and skeletal phenotype of flexed-tail (f/f) mice. Genes Dev (2001) 1.11
Produciton and biological activity of patulin and citrinin from Penicillium expansum. Appl Environ Microbiol (1977) 1.11
Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood (1995) 1.10
Uroporphyrinogen decarboxylase. A method for measuring enzyme activity. Enzyme (1982) 1.10
Successful treatment of a cardiac angiosarcoma with combined modality therapy. J Heart Lung Transplant (1995) 1.09
p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes. EMBO J (1997) 1.09
The prevalence of hypertension among elderly Navajos: a test of the acculturative stress hypothesis. Cult Med Psychiatry (1986) 1.09
Novel bacterial P-type ATPases with histidine-rich heavy-metal-associated sequences. Biochem Biophys Res Commun (1994) 1.09
Biodegradation of Xanthan Gum by Bacillus sp. Appl Environ Microbiol (1982) 1.08
The role of iron in the pathogenesis of porphyria cutanea tarda. An in vitro model. J Clin Invest (1972) 1.06
Hereditary hemochromatosis: contributions of genetic analyses. Prog Hematol (1981) 1.06
Long-range interactions in the dimer interface of ornithine decarboxylase are important for enzyme function. Biochemistry (2001) 1.03
Transferrin receptors of human fibroblasts. Analysis of receptor properties and regulation. Biochem J (1982) 1.03
Production and analysis of citrinin in corn. Appl Environ Microbiol (1978) 1.03
Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes. J Intern Med (1989) 1.03
Characterization and crystallization of human uroporphyrinogen decarboxylase. Protein Sci (1997) 1.02
Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers. Hum Mol Genet (2001) 1.01
Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med (1984) 1.01
Antigen-specific lymphocyte transformation induced by oocyst antigens of Eimeria bovis. Infect Immun (1988) 1.01
Human MafG is a functional partner for p45 NF-E2 in activating globin gene expression. Blood (1997) 1.00
The quality of operative notes at a general surgery unit. S Afr Med J (2008) 1.00
Iron is hot: an update on the pathophysiology of hemochromatosis. Blood (1998) 1.00
Idiopathic refractory sideroblastic anemia: incidence and risk factors for leukemic transformation. Cancer (1979) 1.00
Isolation and characterization of five Drosophila genes that encode an ets-related DNA binding domain. Dev Biol (1992) 1.00
Laboratory diagnosis of the porphyrias. N Engl J Med (1991) 0.99
A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda. Blood (1989) 0.99